Trusted News Discovery Since 2008
{{/content}}
Remdesivir becomes first COVID-19 drug put forward for use in the EU
Video Credit: Euronews English
Published on June 25, 2020 - Duration: 00:34s
Remdesivir becomes first COVID-19 drug put forward for use in the EU
You are here
Related news from verified sources
India's government said on Tuesday it has approved Gilead Sciences Inc's antiviral drug remdesivir for emergency use in treating COVID-19 patients.
on June 2, 2020 • Reuters India
Singapore on Wednesday approved the use of Gilead Sciences Inc's antiviral drug remdesivir for the treatment of severely ill patients with COVID-19 infection.
on June 10, 2020 • Reuters India
Israel approved on Tuesday the use of Gilead Sciences Inc's antiviral drug remdesivir for the treatment of patients with COVID-19 infection.
on June 16, 2020 • Reuters India
Related videos from verified sources
Maker of COVID-19 drug Remdesivir says it will cost about $3,000 per patient 01:47
Video credit: KSWB - Published on June 30, 2020
Gilead's Covid-19 Drug Remdesivir To Cost $2,340-$3,120 Per Patient 00:45
Video credit: Geo Beats - Published on June 29, 2020
Dexamethasone: What is this life saving treatment which is made in India | Oneindia News 00:59
Video credit: Oneindia - Published on June 27, 2020